Health Care: Drugs

Celgene Corporation (CELG: NASDAQ)

$141.51 n/a | n/a%
04/17/14 - 03:59 PM ET
TheStreet Ratings Grade for CELG
BuyHoldSell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F

TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.

Click here to find out about our methodology.

Analyst Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 19 21 22 20
Moderate Buy 2 2 2 2
Hold 3 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.31 1.30 1.25

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter